People with depression can't access potentially life-changing treatment with ketamine because current systems prioritize profits, not patients & payers. New study reveals the systemic barriers that prevent the utilization of existing, low-cost drugs.
From Space, a Vivid Glimpse Into Panama Canal’s Role and Challenges
New study shows surprising effects of fire in North America's boreal forests